185 related articles for article (PubMed ID: 11999897)
1. Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables.
Palego L; Biondi L; Giannaccini G; Sarno N; Elmi S; Ciapparelli A; Cassano GB; Lucacchini A; Martini C; Dell'Osso L
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):473-80. PubMed ID: 11999897
[TBL] [Abstract][Full Text] [Related]
2. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
[TBL] [Abstract][Full Text] [Related]
3. Plasma clozapine, norclozapine, and the clozapine:norclozapine ratio in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 1993-2007.
Couchman L; Morgan PE; Spencer EP; Flanagan RJ
Ther Drug Monit; 2010 Aug; 32(4):438-47. PubMed ID: 20463634
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate.
Centorrino F; Baldessarini RJ; Kando J; Frankenburg FR; Volpicelli SA; Puopolo PR; Flood JG
Am J Psychiatry; 1994 Jan; 151(1):123-5. PubMed ID: 8267110
[TBL] [Abstract][Full Text] [Related]
5. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
[TBL] [Abstract][Full Text] [Related]
6. Estimating the size of the effects of co-medications on plasma clozapine concentrations using a model that controls for clozapine doses and confounding variables.
Diaz FJ; Santoro V; Spina E; Cogollo M; Rivera TE; Botts S; de Leon J
Pharmacopsychiatry; 2008 May; 41(3):81-91. PubMed ID: 18484549
[TBL] [Abstract][Full Text] [Related]
7. Relation of leukocyte counts during clozapine treatment to serum concentrations of clozapine and metabolites.
Centorrino F; Baldessarini RJ; Flood JG; Kando JC; Frankenburg FR
Am J Psychiatry; 1995 Apr; 152(4):610-2. PubMed ID: 7694912
[TBL] [Abstract][Full Text] [Related]
8. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
9. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking.
Hasegawa M; Gutierrez-Esteinou R; Way L; Meltzer HY
J Clin Psychopharmacol; 1993 Dec; 13(6):383-90. PubMed ID: 8120151
[TBL] [Abstract][Full Text] [Related]
10. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
Flanagan RJ; Amin A; Seinen W
Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
[TBL] [Abstract][Full Text] [Related]
11. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
[TBL] [Abstract][Full Text] [Related]
12. Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients.
Centorrino F; Baldessarini RJ; Kando JC; Frankenburg FR; Volpicelli SA; Flood JG
J Clin Psychopharmacol; 1994 Apr; 14(2):119-25. PubMed ID: 8195452
[TBL] [Abstract][Full Text] [Related]
13. Clozapine and norclozapine concentrations in serum and plasma samples from schizophrenic patients.
Hermida J; Paz E; Tutor JC
Ther Drug Monit; 2008 Feb; 30(1):41-5. PubMed ID: 18223461
[TBL] [Abstract][Full Text] [Related]
14. Solid-phase extraction and high-performance liquid chromatographic analysis of clozapine and norclozapine in human plasma.
Freeman DJ; Li MC; Oyewumi K
Ther Drug Monit; 1996 Dec; 18(6):688-92. PubMed ID: 8946666
[TBL] [Abstract][Full Text] [Related]
15. Effect of Valproate and Antidepressant Drugs on Clozapine Metabolism in Patients With Psychotic Mood Disorders.
Marazziti D; Palego L; Betti L; Giannaccini G; Massimetti E; Baroni S; Ciapparelli A; Lucacchini A; Mucci F; DellʼOsso L
Ther Drug Monit; 2018 Aug; 40(4):443-451. PubMed ID: 29601407
[TBL] [Abstract][Full Text] [Related]
16. Plasma clozapine and norclozapine in relation to prescribed dose and other factors in patients aged <18 years: data from a therapeutic drug monitoring service, 1994-2010.
Couchman L; Bowskill SV; Handley S; Patel MX; Flanagan RJ
Early Interv Psychiatry; 2013 May; 7(2):122-30. PubMed ID: 22747759
[TBL] [Abstract][Full Text] [Related]
17. Measurement of Clozapine, Norclozapine, and Amisulpride in Plasma and in Oral Fluid Obtained Using 2 Different Sampling Systems.
Fisher DS; Beyer C; van Schalkwyk G; Seedat S; Flanagan RJ
Ther Drug Monit; 2017 Apr; 39(2):109-117. PubMed ID: 28125503
[TBL] [Abstract][Full Text] [Related]
18. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
Iglesias García C; Iglesias Alonso A; Bobes J
Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
[TBL] [Abstract][Full Text] [Related]
19. Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia.
Tang YL; Mao P; Li FM; Li W; Chen Q; Jiang F; Cai ZJ; Mitchell PB
Br J Clin Pharmacol; 2007 Jul; 64(1):49-56. PubMed ID: 17298477
[TBL] [Abstract][Full Text] [Related]
20. Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography.
Volpicelli SA; Centorrino F; Puopolo PR; Kando J; Frankenburg FR; Baldessarini RJ; Flood JG
Clin Chem; 1993 Aug; 39(8):1656-9. PubMed ID: 8353952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
